Kim SC - Search Results

1

Cardiovascular risk associated with allopurinol vs. benzbromarone in patients with gout.

Kang EH, Park EH, Shin A, Song JS, Kim SC. Kang EH, et al. Among authors: kim sc. Eur Heart J. 2021 Nov 21;42(44):4578-4588. doi: 10.1093/eurheartj/ehab619. Eur Heart J. 2021. PMID: 34508567 Free PMC article.

2

Severe cutaneous reactions requiring hospitalization in allopurinol initiators: a population-based cohort study.

Kim SC, Newcomb C, Margolis D, Roy J, Hennessy S. Kim SC, et al. Arthritis Care Res (Hoboken). 2013 Apr;65(4):578-84. doi: 10.1002/acr.21817. Arthritis Care Res (Hoboken). 2013. PMID: 22899369 Free PMC article.

3

The risk of atrial fibrillation in patients with rheumatoid arthritis.

Kim SC, Liu J, Solomon DH. Kim SC, et al. Ann Rheum Dis. 2014 Jun;73(6):1091-5. doi: 10.1136/annrheumdis-2013-203343. Epub 2013 Apr 20. Ann Rheum Dis. 2014. PMID: 23606703 Free PMC article.

4

Clinical and health care use characteristics of patients newly starting allopurinol, febuxostat, and colchicine for the treatment of gout.

Kim SC, Schmidt BM, Franklin JM, Liu J, Solomon DH, Schneeweiss S. Kim SC, et al. Arthritis Care Res (Hoboken). 2013 Dec;65(12):2008-14. doi: 10.1002/acr.22067. Arthritis Care Res (Hoboken). 2013. PMID: 23861232 Free PMC article.

5

Disease-modifying antirheumatic drug use and the risk of incident hyperlipidemia in patients with early rheumatoid arthritis: a retrospective cohort study.

Desai RJ, Eddings W, Liao KP, Solomon DH, Kim SC. Desai RJ, et al. Among authors: kim sc. Arthritis Care Res (Hoboken). 2015 Apr;67(4):457-66. doi: 10.1002/acr.22483. Arthritis Care Res (Hoboken). 2015. PMID: 25302481 Free PMC article.

6

Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort study.

Kim SC, Glynn RJ, Liu J, Everett BM, Goldfine AB. Kim SC, et al. Acta Diabetol. 2014 Dec;51(6):1015-23. doi: 10.1007/s00592-014-0663-2. Epub 2014 Oct 14. Acta Diabetol. 2014. PMID: 25311055 Free PMC article.

7

Risk of incident diabetes in patients with gout: a cohort study.

Kim SC, Liu J, Solomon DH. Kim SC, et al. Arthritis Rheumatol. 2015 Jan;67(1):273-80. doi: 10.1002/art.38918. Arthritis Rheumatol. 2015. PMID: 25332119 Free PMC article.

8

Effects of xanthine oxidase inhibitors on cardiovascular disease in patients with gout: a cohort study.

Kim SC, Schneeweiss S, Choudhry N, Liu J, Glynn RJ, Solomon DH. Kim SC, et al. Am J Med. 2015 Jun;128(6):653.e7-653.e16. doi: 10.1016/j.amjmed.2015.01.013. Epub 2015 Feb 3. Am J Med. 2015. PMID: 25660249 Free PMC article.

9

Bisphosphonates and risk of cardiovascular events: a meta-analysis.

Kim DH, Rogers JR, Fulchino LA, Kim CA, Solomon DH, Kim SC. Kim DH, et al. Among authors: kim sc, kim ca. PLoS One. 2015 Apr 17;10(4):e0122646. doi: 10.1371/journal.pone.0122646. eCollection 2015. PLoS One. 2015. PMID: 25884398 Free PMC article.

10

Risk of incident atrial fibrillation in gout: a cohort study.

Kim SC, Liu J, Solomon DH. Kim SC, et al. Ann Rheum Dis. 2016 Aug;75(8):1473-8. doi: 10.1136/annrheumdis-2015-208161. Epub 2015 Aug 31. Ann Rheum Dis. 2016. PMID: 26324846 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,312 results

Search Page